Related Experiment Video

Updated: Jun 12, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Cystic fibrosis-related diabetes in children--gaps in the evidence?

Malay Rana1, Craig F Munns, Hiran Selvadurai

  • 1Department of Endocrinology and Diabetes, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, 2145 NSW, Australia.

Nature Reviews. Endocrinology
|May 26, 2010
PubMed

Insights

Cystic fibrosis-related diabetes mellitus is increasing, but screening and management lack standardized guidelines. More research is needed to address treatment and complications for this growing patient population.

Area of Science:

  • Endocrinology
  • Pulmonology
  • Metabolic Disorders

Background:

  • Increasing life expectancy in cystic fibrosis (CF) patients has led to a higher prevalence of CF-related diabetes mellitus (CFRDM).
  • Current screening practices for CFRDM are inconsistent, hindering accurate assessment of its health burden.
  • Effective management strategies for CFRDM, including prediabetes and hyperglycemia, are lacking.

Purpose of the Study:

  • To highlight the growing need for evidence-based guidelines in screening and management of CFRDM.
  • To identify gaps in current research regarding CFRDM treatment and complication prevention.
  • To emphasize the necessity of a robust evidence base for clinical practice.

Main Methods:

  • Review of existing literature on CFRDM screening, treatment, and complications.
  • Analysis of current management practices and their limitations.
  • Identification of areas requiring further research and intervention studies.

Main Results:

  • Wide variations in CFRDM screening practices exist, impacting prevalence estimates.
  • Limited evidence supports insulin use for impaired glucose tolerance in CF patients.
  • Nutritional management for CFRDM lacks specific evidence-based recommendations.
  • Microvascular complications are increasingly prevalent, with no intervention studies on prevention or management.

Conclusions:

  • There is a critical need for standardized screening protocols for CFRDM.
  • Further research is essential to establish effective insulin and nutritional therapies for CFRDM.
  • Intervention studies are required to address the prevention and management of diabetic complications in CF patients.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...